SCHEMBL17669191

SCHEMBL17669191

Cc1cccnc1N(C(=O)c1ccc(Br)cn1)C1CCCN(C(=O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPLP1 P05386 6/20 0.43
RPLP0 P05388 6/20 0.43
RPS17 P08708 6/20 0.43
RPSA P08865 6/20 0.43
RPS2 P15880 6/20 0.43
RPL35A P18077 6/20 0.43
RPL7 P18124 6/20 0.43
RPL17 P18621 6/20 0.43
RPS4Y1 P22090 6/20 0.43
RPS3 P23396 6/20 0.43
RPS12 P25398 6/20 0.43
RPL13 P26373 6/20 0.43
RPL10 P27635 6/20 0.43
RPL12 P30050 6/20 0.43
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 6/20 0.43
RPL22 P35268 6/20 0.43
RPL4 P36578 6/20 0.43
RPS19 P39019 6/20 0.43
RPL3 P39023 6/20 0.43
RPL13A P40429 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17669190 1.00 RPLP1 (0.43) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL17669165 0.89 PCSK9 (0.47) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL17679166 0.88 USP30 (0.41) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL16177743 0.88 PCSK9 (0.47) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL31227777 0.84 RPLP1 (0.33) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL17669212 0.79 PCSK9 (0.47) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL16177121 0.76 PCSK9 (0.47) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL16177414 0.76 USP30 (0.46) KCNH2PCSK9
SCHEMBL16187367 0.76 USP30 (0.46) KCNH2PCSK9
SCHEMBL16177311 0.74 PCSK9 (0.42) RPLP1RPLP0RPS17RPSARPS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055901-A1 SUBSTITUTED AMIDE COMPOUNDS PFIZER INC. (US) 2016-04-14 WO disclosed
US-20160102074-A1 SUBSTITUTED AMIDE COMPOUNDS PFIZER INC. (US) 2016-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102074-A1 SUBSTITUTED AMIDE COMPOUNDS CETP, APOB, LCAT RPLP1 3305/4885RPLP0 2629/4885RPS17 3679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.